An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin.
Posted from: this blog via Microsoft Power Automate.